Table 3.
Number (%) of selected reports of trials of pharmaceutical and nonpharmaceutical treatments for hip and knee osteoarthritis that described the intervention
| Reports | Reporting of | N (%) |
|---|---|---|
|
Pharmacologic Treatment (N=30) |
Mode of administration | 30 (100) |
| Dosage | 30 (100) | |
| Duration of treatment | 30 (100) | |
| Frequency of treatment | 30 (100) | |
| Compliance of patients | 10 (33) | |
|
Surgery (N=30) |
Type of anesthesia | 4 (13) |
| Pre-operative care | 2 (7) | |
| Post-operative care | 15 (50) | |
| Technical procedure | 30 (100) | |
| Compliance of care providers | 0 | |
|
Rehabilitation (N=30) |
Number of sessions | 29 (97) |
| Timing of sessions | 26 (87) | |
| Duration of each session | 24 (80) | |
| Content of each session | 28 (93) | |
| Mode of delivery | 27 (90) | |
| Supervision or not | 25 (83) | |
| Compliance of patients | 15 (50) | |
|
Devices (N=30) |
Manufacturer | 9 (30) |
| Description of the device | 28 (93) | |
| Compliance of patients | 9 (30) |